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Knockout studies have shown that the poly-
comb gene Bmi-1 is important for postnatal,
but not embryonic, neural stem cell (NSC) self-
renewal and have identified the cell-cycle inhib-
itors p16/p19 as molecular targets. Here, using
lentiviral-delivered shRNAs in vitro and in vivo,
we determined that Bmi-1 is also important for
NSC self-renewal in the embryo. We found
that neural progenitors depend increasingly on
Bmi-1 for proliferation as development pro-
ceeds from embryonic through adult stages.
AcuteshRNA-mediatedBmi-1 reductioncauses
defects in embryonic and adult NSC prolifera-
tion and self-renewal that, unexpectedly, are
mediated by a different cell-cycle inhibitor, p21.
Gene array analyses revealed developmental
differences in Bmi-1-controlled expression of
genes in the p21-Rb cell cycle regulatory path-
way. Our data therefore implicate p21 as an
important Bmi-1 target in NSCs, potentially
with stage-related differences. Understanding
stage-related mechanisms underlying NSC
self-renewal has important implications for de-
velopment of stem cell-based therapies.
INTRODUCTION
Neural stem cells (NSCs) proliferate during development
to form neural tissues, and continue to divide into adult-
hood where they produce new cells throughout life, in-
cluding olfactory neurons in the forebrain subventricular
zone (SVZ) and granule neurons in the hippocampal
dentate gyrus. NSCs produce different types of progeny
at different times during development, and it is important
to understand how their proliferation is regulated to ensure
appropriate cell generation. As development progresses,
the stem cell population decreases and their proliferationdeclines to low levels; the remaining stem cells must be
tightly regulated to ensure they do not hyperproliferate in
adult tissues. Therefore, self-renewal mechanisms are
likely to change as stem cells mature.
Polycomb group (PcG) genes are epigenetic gene si-
lencers that preserve transcription patterns to maintain
cell identity (Lund and van Lohuizen, 2004; Buszczak
and Spradling, 2006), a function clearly compatible with
a role in self-renewal. At postnatal stages, knockout of
Bmi-1, a member of the polycomb family, has a profound
effect on NSCs (Molofsky et al., 2003; Zencak et al., 2005),
reducing forebrain SVZ neurosphere frequency by 80% at
30 days after birth (Molofsky et al., 2003). With time in cul-
ture, neurospheres derived from all stages, including em-
bryonic, showed a dependence on Bmi-1 for self-renewal,
displaying amarked reduction in secondary sphere forma-
tion. The dependence on Bmi-1 for stem cell maintenance
has been explained by Bmi-1-mediated suppression of
the Ink4a/ARF cell cycle inhibitory proteins, p16 and
p19, whose activities increase with postnatal age and
time in culture, and which are upregulated further in the
Bmi-1 knockout mouse compared to wild-type (Jacobs
et al., 1999; Molofsky et al., 2003). In contrast to these
postnatal findings, Bmi-1 knockout has only a modest
effect on the incidence of CNS forebrain stem cells at
embryonic stages through birth, when the vast majority
of diverse neural cells are generated. The mechanisms
underlying self-renewal at these stages are unclear, and
the reason for their reduced dependence on Bmi-1 is
unknown.
Understanding the molecular events downstream of
Bmi-1 should provide valuable insight into how NSCs de-
rived from different stages differentially regulate prolifera-
tion and self-renewal. Although p16 and p19 have been
shown to be Bmi-1 targets in the context of stem cell
self-renewal, they do not account for all Bmi-1 actions,
and other downstream effectors are being sought (Spar-
mann and Van Lohuizen, 2006). Here we investigated
the role ofBmi-1 by using lentiviral-mediated RNA interfer-
ence to reduce Bmi-1 levels in neural progenitor cells
(NPCs) at different times during development, and then
assessing downstream gene changes at the onset of theCell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc. 87
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ating cells present in CNS germinal zones, including
NSCs and restricted progenitors such as neuroblasts
and glioblasts). This approach provides information as to
which genes are immediately affected byBmi-1 loss at dif-
ferent developmental stages, and which could initiate the
loss of self-renewal phenotype.
Given the Bmi-1 knockout findings of little effect on pro-
liferation or cell death in the embryonic brain, we expected
a mild phenotype after Bmi-1 reduction at embryonic
stages. Surprisingly, we found that acute reduction of
Bmi-1 via shRNA expression in cortical NPCs results in
rapidly impaired proliferation and self-renewal and in-
creased cell death as early as embryonic day 11 (E11). An-
other unexpected finding was that the levels of p16 and
p19 appeared unchanged 48 hr posttreatment, suggest-
ing that Bmi-1 shRNA initiates changes in proliferation
and self-renewal via a different mechanism from Ink4a/
ARF product upregulation. Instead, the cell-cycle inhibitor
p21/Cip1, founding member of the Cip/Kip family of cy-
clin-dependent kinase inhibitors, was rapidly upregulated
after Bmi-1 shRNA at all stages examined. This focuses
our attention on Bmi-1-dependent p21 regulation as a
key factor in NSC self-renewal throughout development.
Moreover, we found evidence by gene expression analy-
ses for differential repression of genes involved in the
p21-Rb pathway in a stage-specific manner. As Bmi-1
can be upregulated in brain tumors (Hemmati et al.,
2003; Leung et al., 2004), recognizing the importance of
the p21-Rb pathway as aBmi-1 target could be significant
for molecular oncology as well as NSC biology.
RESULTS
shRNAs Specifically Reduce Bmi-1 in E11 NPCs,
Resulting in Impaired Proliferation
We tested three lentiviral-based vectors against Bmi-1
that express an RNAi-inducing shRNA under control of
the H1 promoter and that coexpress enhanced green
fluorescent protein (eGFP) from the ubiquitin promoter
(Ivanova et al., 2006), and a lentiviral vector expressing
the Bmi-1 open reading frame (ORF) that enforces Bmi-1
expression (pUbqC-Bmi-1) (Figure 1A). shRNAs were de-
signed to target either the Bmi-1 ORF or the 30UTR and
were shown by real-time quantitative PCR and western
blotting to reduce Bmi-1 transcript and protein, while the
expression vector increased protein levels after 48 hr (Fig-
ures 1B and 1C).
We first examined the effect of Bmi-1 knockdown in the
E11 cerebral cortex, as we have previously characterized
these NPCs extensively in terms of proliferation and neu-
ron and glial generation (Qian et al., 2000; Shen et al.,
2006). We transduced the cells in vitro with Bmi-1 shRNA
vectors and then grew them in neurosphere-generating
conditions. Primary neurospheres were subcloned to ex-
amine secondary neurosphere formation: a measure of
NSC expansion.
No differences in primary or secondary neurosphere fre-
quency between untransduced cells and cells transduced88 Cell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc.with a control empty vector (EV) expressing eGFP were
observed (Figures 1D–1F). However, when cells were
transduced with lentiviral constructs expressing an
shRNA targeted against Bmi-1, there was a decrease in
neurosphere frequency and size, with the phenotype
becoming more marked with passage from primary to
secondary neurospheres (Figures 1D–1F). Three indepen-
dently designed shRNAs against Bmi-1 resulted in similar
phenotypes in the neurosphere assay, suggesting that the
RNAi-mediated knockdown is specific (Figure 1D). How-
ever, as a further control, we attempted to rescue the
Bmi-1 RNAi phenotype. Isolated E11 cortical progenitors
were transduced with a lentiviral vector expressing the
Bmi-1 ORF (pUbqC-Bmi-1), or cotransduced with
pUbqC-Bmi-1 and an shRNA construct specifically tar-
geted to the Bmi-1 30UTR. Enforced Bmi-1 expression re-
sults in a higher frequency of secondary neurospheres,
while cells cotransduced are not significantly different
from controls (Figures 1E and 1F). This shows that the
Bmi-1 shRNA knockdown could be complemented by
exogenous Bmi-1, supporting the specificity of the
RNAi-induced phenotype.
Bmi-1 shRNA Impairs NSC Proliferation
Increasingly through Development
We hypothesized that acute knockdown of Bmi-1 might
lead to an increasingly severe phenotype in a stage-
dependent manner. Cortical progenitors from E11, E14,
and E16, and SVZ cells from P0 and adult, were isolated,
transduced with Bmi-1 shRNA lentiviral constructs, and
cultured in neurosphere-forming conditions for 7 days.
We observed a progressive increase in the dependence
on Bmi-1 for proliferation and neurosphere formation
with stage (Figure 2A). The phenotype is stronger at late
embryonic stages compared to E11, and by adulthood,
Bmi-1 shRNA virtually eliminated neurosphere-generating
ability. To exclude the possibility that differences in RNAi
efficacy contributed to the phenotype, we isolated RNA
from cells 48 hr after transduction, and real-time quantita-
tive PCR analyses show similar levels of Bmi-1 transcript
reduction (60%) from cells isolated at each developmen-
tal stage (see Figure S1A in the Supplemental Data avail-
able with this article online).
To further examine the effect of Bmi-1 shRNA on NPC
behavior, transduced cells were cultured for 7 days as ad-
herent clones, and then clone composition was examined
with cell type-specific markers. The total cell number and
the numbers of Nestin+ progenitor cells weremarkedly re-
duced after shRNA Bmi-1 treatment but were not signifi-
cantly different in cells transduced with EV control or co-
transduced with both shRNA Bmi-1 and pUbqC-Bmi-1
(Figures 2B and 2C). The total number of b-tubulin III+ cells
(a marker expressed by neurons) was unchanged in all
conditions, even after Bmi-1 shRNA. Expression of
NG2+ (a marker expressed by oligodendroglial progenitor
cells, which arise at midgestation in the forebrain) was re-
duced relative to EV control-transduced cultures after
Bmi-1 shRNA at E14 and E16 (Figure 2C), and GFAP ex-
pression was negligible (data not shown), revealing
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(A) Diagram of the shRNA-expressing and Bmi-1-expressing lentiviral constructs.
(B) E11 NPCs from E11 cortices were transduced with control or differentBmi-1 shRNA lentivectors and then cultured in adherent conditions for 48 hr.
mRNA was isolated and real-time quantitative PCR was performed to determine the level of Bmi-1 transcripts. Expression levels were normalized for
GAPDH. Error bars, SD between four experiments.
(C) Western blot of protein samples isolated from E11 cortical NPCs transduced with EV control, Bmi-1ORF shRNA,Bmi-1 30UTR shRNA, or pUbqC-
Bmi-1 (expression) lentiviruses.
(D) Frequency of primary neurospheres assessed at 7 days, at which point they were passaged and secondary neurosphere frequency was assessed
at a further 7 days. Neurosphere frequencies were normalized tomock-transduced cells. Error bars, SE from four experiments. ANOVAwas usedwith
Bonferonni post-hoc test., #p < 0.05, *p < 0.001 compared to mock control.
(E) Secondary neurosphere frequencies after lentiviral transduction of E11 cortical progenitors with shRNABmi-1 30UTR are different from EV control,
*p < 0.0001 and #p < 0.05. Cells cotransduced with both the shRNA Bmi-1 30UTR and pUbqC-Bmi-1 lentiviruses show no significant difference in the
frequency of secondary neurospheres compared to controls.
(F) Sizes of E11 neurospheres at 7 days as percent change from control, *p < 0.01, #p < 0.01.a strong impairment of glial cell generation. Similar find-
ings were observed with two different Bmi-1 shRNA vec-
tors (data not shown).
Acute Reduction of Bmi-1 in NPCs Increases
p21 Rather Than p16/p19
The shRNA technique allows assessment of acute
changes after gene reduction, revealing the time course
of events leading to a phenotype. To determine the
changes associated with Bmi-1 shRNA treatment, we iso-
lated E11 cerebral cortical progenitor cells, plated individ-
ual Bmi-1 shRNA-transduced cells in adherent microcul-ture, and then followed them as they developed into
clones. As early as 48 hr after plating, we observed a pro-
found decrease in the proliferative marker Ki67 (Figure 3A)
and an increase in cell death, revealed by caspase 3 stain-
ing, compared to EV control transduction (Figure 3A). This
showed that there were rapid changes in cell survival and
proliferation, and we then looked for mechanism.
Expression from the Ink4a/ARF locus has not been
detected in acutely isolated NPCs from either wild-type
or Bmi-1 null embryonic mice (Molofsky et al., 2003), sug-
gesting that the RNAi phenotype we observed in embry-
onic cells may be independent of this locus. ConsistentCell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc. 89
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Bmi-1 Represses p21 in NSCsFigure 2. NPCs Require Bmi-1 for Proliferation and Survival and Have Increased Dependence on Bmi-1 through Development
(A) Neurosphere initiating cell frequency expressed as percent change from control, *p < 0.05, #p < 0.001, EV control versus Bmi-1 shRNA treatment
and ##p < 0.0001 for E11 shRNA versus adult shRNA.
(B and C) E11, E14, and E16 cortical NPCs were plated at clonal density in microwells and cultured for 7 days. The resulting colonies were examined
by immunostaining for Nestin+ progenitor cells, NG2+ glial progenitor cells, and b-tubulin III+ neurons. There is a decrease in total and Nestin+ cells
and in NG2+ glial progenitor cells at all stages, *p < 0.0001 compared to EV control. However, the number of b-tubulin III+ cells appears unaffected
after Bmi-1 shRNA at 7 days. Error bars, SE from four experiments. ANOVA was used with Bonferonni post-hoc test, Scale bar, 30 mm.with this, we found no detectable increase in either p16 or
p19 in embryonic stage cells after 48 hr of Bmi-1 shRNA
treatment (data not shown), even though there was a clear
phenotype at this time (Figure 3A). Surprisingly, we were
also unable to detect an increase in p16 or p19 mRNA in
P0 or adult SVZ cells after acute Bmi-1 knockdown at
48 hr (Figure 3B), even though we could measure a de-
crease after Bmi-1 overexpression, demonstrating that
we could detect changes in Ink4a/Arf message level.
These results suggest that the immediate shRNA pheno-
type may be initiated independently of this locus even at
postnatal stages. In contrast, at all embryonic and postna-
tal ages we detected an increase in expression of p21/
Cip1mRNA suggesting that Bmi-1might additionally reg-
ulate this alternative cell cycle inhibitory pathway (Fig-
ure 3C). p21 increased expression has been noted after
Bmi-1 knockout (Molofsky et al., 2003), but its functional
relevance has not been tested in this context.
p21 shRNA Rescues the Early Antiproliferative
Bmi-1 shRNA Phenotype
To investigate a functional role for p21 in Bmi-1-depen-
dent proliferation, we generated two different p21 shRNA
constructs that effectively reducedp21protein (Figure 4A).
NPCs from E11 cortex were transduced with Bmi-190 Cell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc.shRNA or p21 shRNA, alone or together, and were then
cultured for 48 hr as adherent clones; transcripts were
reduced to a similar level after single transduction or
cotransduction (Figure 4B). As shown above, 48 hr after
Bmi-1 shRNA treatment there were fewer total cells and
proliferation was decreased. After p21 shRNA treatment,
cell number and proliferation did not differ from control.
However, when Bmi-1 shRNA was combined with p21
shRNA, the phenotype was rescued (Figures 4C and
4D). This strongly suggests that changes in p21 initiate
the Bmi-1 shRNA phenotype. We then examined whether
p16 or p19 were involved in these early stages. Treatment
of E11 cortical cells with a knockdown construct targeting
both p16 and p19 (Ink4a/ARF shRNA) decreased p16 and
p19 transcript levels at 48 hr (Figure 4B and Figure S2),
and we found that the phenotype of the transduced corti-
cal cells did not differ from EV control (Figures 4C and 4D).
However, Ink4a/ARF shRNA in combination with Bmi-1
shRNA did not rescue the total cell number or incidence
of proliferating cells (Figures 4C and 4D).
To explore later stages of the phenotype, NPCs from
E11 cortex and adult SVZ were transduced with Bmi-1
and p21 shRNA viral vectors, alone or together, and then
plated in neurosphere-forming conditions for 7 days.
Bmi-1 shRNAdecreases the frequency and size of primary
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Bmi-1 Represses p21 in NSCsFigure 3. Acute Loss of Bmi-1 Impairs Cell Survival and Division and Increases p21/Cip, but Not p16/p19, Expression
(A) Adherent E11 cortical cultures transduced with Bmi-1 shRNA at the time of plating (eGFP, green), immunostained for the proliferation marker Ki67
(top panels, red) and the apoptosis marker caspase 3 (bottom panels, red) at 48 hr and 7 days posttransduction. Scale bar, 30 mm.
(B) Real-time PCR after 48 hr of Bmi-1 shRNA treatment; expression levels normalized for GAPDH. No detectable increase of p16 or p19 transcripts
after transduction with Bmi-1 shRNA lentiviral vectors in P0 or adult NPCs.
(C) p21 expression increases in NPCs at all stages tested. Error bars, SD between four experiments.neurospheres, but p21 shRNA alone had no significant ef-
fect on primary neurosphere formation (Figures 5A–5C).
Embryonic primary neurosphere frequency was partially
rescued by Bmi-1/p21 co-shRNA to 80% of control, while
adult SVZ primary neurosphere frequency was completely
rescued (Figures 5A and 5C). Neurosphere size was com-
pletely rescued at both embryonic and adult stages, al-
though we noted a trend toward smaller spheres in the
adult (Figures 5B and 5C). Further, secondary sphere fre-
quency (Figure S3A) and size (data not shown) were no dif-
ferent than EV control afterBmi-1/p21 shRNAcotransduc-
tion, demonstrating that the rescue persists in passaged
spheres. We then compared the effect of combining
Bmi-1 and INK4a/ARF shRNAs in E11 cells plated in neu-
rosphere-generating conditions. After 7 days in culture,
there was no significant difference in primary neurosphere
frequency and size compared to Bmi-1 shRNA (Figures
S3B and S3C). This result echoes the 48 hr data, in which
INK4a/ARF shRNA does not rescue the early proliferative
defect. These data, taken together with the 48 hr data,
strongly implicate p21 at the onset of the antiproliferative
phenotype caused by Bmi-1 reduction.
Bmi-1 shRNA Impairs NPC Survival
and Proliferation In Vivo
Our data suggest that Bmi-1 is important for NPC prolifer-
ation at embryonic stages and that it acts via p21 suppres-sion. To demonstrate that this occurs in vivo, we first elec-
troporated in utero EV control versus Bmi-1 shRNA
plasmids into forebrain lateral ventricles of E14 mice,
and 3 days later sacrificed the mice and examined cryo-
stat forebrain sections.
In the hemisphere in whichBmi-1 shRNA plasmids were
electroporated, the lateral ventricle was typically enlarged
and the germinal zone was thinner compared to the non-
injected side (Figure 6A). Numbers of eGFP+ cells in the
germinal zones (ventricular and SVZ), the intermediate
zone, and cortical plate were all significantly reduced after
Bmi-1 shRNA compared to EV control (Figures 6B and
6C). Using a TUNEL assay, we observed an increase in
apoptosis in the Bmi-1 shRNA-treated hemisphere
compared to EV control-treated cortex (Figure 6D) or to
nontransduced tissue (data not shown). In EV control-
transduced and nontransduced cortex, Nestin+ progeni-
tor cells have their cell bodies in the germinal zone and ex-
tend processes radially toward the pial surface (Figure S4).
In contrast, in theBmi-1 shRNA electroporated cortex, the
profile of Nestin+ cells was distorted, fibers appeared bro-
ken, and radial fiber numbers were reduced (Figure S4).
These data show that Bmi-1 is important for NPC prolifer-
ation and survival at embryonic stages in vivo.
In order to determine whether the mechanism of action
of Bmi-1 in vivo was p21 dependent, we examined the ef-
fect of electroporating p21 shRNA plasmids. p21 shRNACell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc. 91
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Bmi-1 Represses p21 in NSCsFigure 4. p21 shRNA, but Not Ink4a/ARF shRNA, Rescues the Early Bmi-1 shRNA Phenotype
(A) Western blot showing the efficacy of two different p21 shRNA constructs in Mbend cells.
(B) Real-time PCR showing reduction of transcript expression after single-transduced and cotransduced shRNA treatment of E11 cortical cells at
48 hr (top). Reverse transcriptase-PCR showing reduction of Ink4a/ARF transcript after shRNA treatment of E11 cortical cells at 48 hr (bottom).
(C) p21, but not p16/p19, rescues cell number at 48 hr.
(D) Adherent E11 cortical cell cultures transducedwithBmi-1, p21, and Ink4a/ARF shRNAs alone or in combination at the time of plating (eGFP, green)
and immunostained for the proliferative marker Ki67 (red) at 48 hr posttransduction. Bmi-1 shRNA results in fewer total cells and fewer Ki67+ cells
compared to EV control; this is rescued with p21 shRNA, but not with Ink4a/ARF shRNA. Blue, DAPI. Error bars, SE; and ANOVA with *p < 0.001 and
#p < 0.0001 from four experiments.alone had no detectable effect 3 days posttreatment com-
pared to EV control (data not shown). However, when
Bmi-1 and p21 shRNA plasmids were electroporated to-
gether, the proliferative capacity was restored and cell
death was reduced, yielding an eGFP+ cell profile similar
to that of the EV control, including a restoration of cell
number in VZ/SVZ germinal zones (Figures 6B–6D). These
data show that p21 knockdown can rescue the antiproli-
ferative and proapoptotic effects of acute Bmi-1 knock-
down in vivo.
Gene Expression Analysis after Acute
Bmi-1 Reduction
As the effects of Bmi-1 knockdown became more pro-
found with stage, we reasoned that the genes regulated
by Bmi-1 might also differ with stage. To investigate this,92 Cell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc.we used Agilent microarrays to make genome-wide mea-
surements of transcript prevalence in NPCs after Bmi-1
shRNA treatment. We calculated the log2 ratios of gene
expression in NPCs isolated from E11, E14, and E16,
48 hr after Bmi-1 shRNA lentiviral transduction compared
to EV control transduction (Table S1), and used hierarchi-
cal clustering to visualize gene expression changes. The
genes that showed an expression change of at least
a log2 ratio of ±0.5 in any one of the three ages are shown
(Figure 7A).
There are shared transcriptional consequences of Bmi-
1 knockdown between the three developmental stages in-
vestigated, for example in changes in cell-cycle compo-
nents. We also found a subset of potential downstream
targets that are affected in a stage-dependent manner.
To explore possible functional significance, we mapped
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Bmi-1 Represses p21 in NSCsFigure 5. p21 shRNA Rescues the Bmi-1 shRNA Neurosphere Phenotype
NPCs from E11 cortex or adult SVZ were transduced with Bmi-1 shRNA and p21 shRNA, alone or together, and grown in neurosphere conditions. (A)
Neurosphere frequency, (B) neurosphere size. Bmi-1 shRNA decreases primary neurosphere frequency and size, while p21 shRNA had no significant
effect compared to EV control. Cotransduction of p21 and Bmi-1 shRNAs significantly rescued neurosphere size and frequency measured at 7 days
after transduction in both E11 and adult cells. (C) Fluorescent micrographs of E11 cortical neurospheres (left panels) and adult SVZ neurospheres
(right panels). Error bars, SE from four experiments. Statistical test: ANOVA followed with Bonferroni post-hoc test, for treatments versus EV control,
*p < 0.05, **p < 0.01, and #p < 0.001. Scale bar, 100 mm.genes most highly overexpressed after Bmi-1 reduction at
each stage onto gene ontology (GO) terms. As shown for
selected GO terms, overall gene expression changes are
more pronounced at later developmental stages, consis-
tent with the increasing severity of the Bmi-1 shRNA phe-
notype (Figures 7B and 2A); this pattern does not hold for
neurogenesis-related genes, whose peak misexpression
after acute Bmi-1 reduction occurs at E14, not E16, coin-
cident with the peak of embryonic neurogenesis.
To extend our analysis of gene expression changes
after acute Bmi-1 reduction, we measured transcript
abundance using real-time quantitative PCR. We chose
genes whose expression levels were previously shown
to be affected in the Bmi-1 knockout, lineage markers,
and selected genes from the microarray. We found
stage-related differences in many of the tested genes, in-
cluding HoxC9 and HoxD9, which were previously shown
to be upregulated in the Bmi-1 knockout (Figure S5). Inter-
estingly, the neural progenitor markers Olig1 and Mash1
were repressed at E11 but appeared unaffected at E16,
consistent with their normal increased expression in pro-
genitor cells during embryonic development.Given that Bmi-1 reduction caused a marked impair-
ment of cell division at E11 and more so at E16, we inves-
tigated cell cycle regulatory genes and noted age-related
differences. As shown above, when Bmi-1 is reduced
there is an upregulation of p21 (Figures 3C and 4B). Inter-
estingly, other transcripts involved in the p21-Rb pathway
also change, and some do so differently with stage. For
example, the Rb interacting factors and cell-cycle inhibi-
tors Ctbp1 and E4F1 (Fajas et al., 2000) are decreased
at E11 but increased at E16 (Figure 7C and Figure S5).
Moreover, we found that at E11 there are differential
changes in the expression of Tcf4 and Id2, which can
also impact Rb function (Tetsu and McCormick, 1999;
Lasorella et al., 2005). Thus Bmi-1 knockdown results in
stage-related changes in known p21-Rb pathway inter-
acting factors.
DISCUSSION
It is important to elucidate molecular mechanisms under-
lying NSC self-renewal in order to understand normal CNS
development, and to develop therapies for neuralCell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc. 93
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Bmi-1 Represses p21 in NSCsFigure 6. Electroporation of shRNA Bmi-1 Plasmid In Utero Results in Cortical Cell Death and NPC Loss
Micrographs of E17 forebrain coronal sections 3 days after Bmi-1 electroporation.
(A) Low power image showing Bmi-1 shRNA electroporation (right panel) versus contralateral hemisphere without electroporation (left panel). Bmi-1
shRNA results in enlarged ventricles, a thinner cortex, and a smaller germinal zone.
(B) After Bmi-1 shRNA, there are fewer total eGFP+ cells. However, cotransduction of p21 shRNA with Bmi-1 shRNA appears similar to EV control
plasmid transduction (eGFP, green).
(C) Numbers of GFP cells in the major cortical regions—the germinal zone (VZ/VZ), the intermediate zone (IZ), and the cortical plate (CP).
(D) Increased apoptosis was seen by TUNEL assay after Bmi-1 shRNA treatment in vivo compared to EV control plasmid (green, eGFP; red, TUNEL).
This increase in cell death after Bmi-1 shRNA is rescued by cotransduction with p21 shRNA. Error bars, SE; and ANOVA, *p < 0.001, #p < 0.005, and
**p < 0.005. Scale bar: (A) 100 mm, (B) 50 mm, and (D) 20 mm.pathologies. Here we show that the polycomb geneBmi-1
is important for NSC proliferation throughout development
and that it functions in part via p21 repression. We provide
evidence that Bmi-1 differentially regulates genes in the
p21-Rb pathway at different stages of development. In
addition, this study demonstrates the utility of lentiviral-
mediated shRNA knockdown to elucidate gene function:
because it reveals the effects of acute gene product re-
duction, it can provide different information from knockout
approaches.
In our studies, Bmi-1 knockdown resulted in a profound
decrease in progenitor proliferation and an increase in cell
death even in embryonic stage cells. This occurred in cul-
tured cells and also after electroporation in vivo, after
which radial progenitor cells were depleted and cells be-
came skewed toward differentiation. We conclude that94 Cell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc.Bmi-1 is critical for NPC survival and proliferation during
forebrain development. This contrasts with the mild phe-
notype after Bmi-1 knockout, in which neurosphere fre-
quency is reduced by only 0.3% at E14 and forebrain de-
velopment appears normal with no signs of apoptosis
(Molofsky et al., 2003). It is unlikely that the Bmi-1 knock-
down phenotype is due to off-target effects because we
have demonstrated similar phenotypes using different
Bmi-1 shRNA vectors and a rescue by replacing endoge-
nous Bmi-1 by expressing its ORF. One possible explana-
tion for the differences revealed by Bmi-1 shRNA knock-
down compared to the Bmi-1 knockout, is that the
knockout mouse has developed compensatory mecha-
nisms allowing continued NPC proliferation and self-
renewal during embryogenesis. Cell-cycle regulation is
governed by a highly complex network that offers many
Cell Stem Cell
Bmi-1 Represses p21 in NSCsFigure 7. Expression Profiling Reveals Stage-Dependent Changes in Global Gene Expression after Acute Bmi-1 Reduction
(A) The genome-wide transcriptional profile of E11, E14, and E16 cortical progenitors after Bmi-1 shRNAwasmeasured using Agilent oligo arrays. On
a genome-wide scale, the gene expression consequences of acute reduction ofBmi-1 levels are only partially overlapping between E11, E14, and E16
neural progenitors as shown by the Pearson correlation coefficients (E11 versus E14, 0.39; E14 versus E16, 0.31). Genes putatively upregulated after
acute Bmi-1 reduction were mapped onto GO terms for each stage. The relative enrichment of selected terms is presented in (B). The consequences
of acute Bmi-1 reduction increase with age as 245, 311, and 501 genes were included in this analysis for E11, E14, and E16 NPCs, respectively. The
ratio of genes upregulated at a given age over the total genes in a selected GO category over all ages is presented. We selected GO categories con-
sistent with Bmi-1 function and found that the enrichment between these categories was higher at E16, except for neurogenesis-related genes that
showed greater enrichment at E14. (C) We then examined and verified gene changes involved in the p21-Rb pathway using real-time quantitative
PCR. Expression levels of select genes were normalized for GAPDH and were displayed as the ratio between Bmi-1 shRNA and matched EV control
cells. Error bars, SD between four experiments.avenues for compensation. Reduction of other cell cycle
interacting components, for example cdk2, also has dif-
ferent consequences in acute versus chronic loss situa-
tions, (Blagosklonny, 2004); hence, this may be a common
finding when experimentally perturbing components of
this network. Moreover, during embryonic development
when cell proliferation is a highly robust process, the pos-
sibilities for circumventing loss of self-renewal/prolifera-
tion factorsmay be broader than at adult stageswhen pro-
liferation is less frequent and held under tight control.
Surprisingly, given our expectations from the knockout
results, we found no evidence of an increase in either
p16 or p19 at any developmental stage 48 hr after reduc-
tion of Bmi-1. Moreover, verified Ink4a/ARF knockdown
with shRNA did not rescue the antiproliferative and proa-
poptotic phenotype of Bmi-1 knockdown in 48 hr cultures
or primary neurospheres at 7 days. These data suggest
that the RNAi-revealed phenotype is not initiated by in-
creased expression from the Ink4a/ARF locus (Figures 3
and 4). Increased expression from this locus occurs withage (Molofsky et al., 2006) and time in culture (Zindy
et al., 1997); hence, p16/p19 may be upregulated at later
time points after Bmi-1 shRNA begins to take effect.
These data also suggest that the effects of p21 are not
mediated indirectly through p19, which is a known regula-
tor of the p53-p21 pathway. Our data do not firmly exclude
a role for p16/p19 because we reduced rather than elimi-
nated their expression. An alternative approach would
have been to use NSCs from p19ARF null mice. However,
we chose to use the shRNA approach for consistency and
because it is possible that p19ARF null mice have altered
self-renewal control due to chronic loss. Nevertheless, it
will be interesting to examine whether p21 shRNA can res-
cue the Bmi-1 shRNA phenotype in p19ARF null cells in
the future.
Our finding that Bmi-1 acute knockdown resulted in
rapidly increased p21 expression was robust at all ages
examined. An increase in p21 levels inhibits cyclin E/
cdk4 to prevent Rb phosphorylation and maintain a stable
Rb-E2F complex, thus repressing cell-cycle progressionCell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc. 95
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Dyson, 1998). Our data suggest that Bmi-1 represses p21
and that acute reduction of Bmi-1 relieves this repression,
allowing p21 transcription and thereby promoting cell-
cycle exit. p21 has been previously shown to be upregu-
lated in cortical progenitor cells exiting the cell cycle (Sie-
genthaler and Miller, 2005) and also to regulate postnatal
NSC proliferation and self-renewal (Kippin et al., 2005; Qiu
et al., 2004; Ligon et al., 2007). Moreover, an upregulation
of p21 mRNA has been noted in the Bmi-1 knockout
(Molofsky et al., 2003). We now provide functional evi-
dence for a role of p21 in NSC proliferation downstream
of Bmi-1. At 48 hr, p21 shRNA produced a significant
rescue of the antiproliferative Bmi-1 shRNA phenotype,
which was sustained over the next 2 weeks of culture as
primary and secondary neurospheres. These data sug-
gest that activation of the p21 pathway may be one of
the initial steps in the Bmi-1 shRNA antiproliferative pro-
cess and might be a key target of Bmi-1-mediated repres-
sion in self-renewing NSCs.
We observed an increase in dependence on Bmi-1 for
NPC proliferation andNSC self-renewal with developmen-
tal stage. This could be due to a number of factors, such
as a reduction of endogenous Bmi-1 levels with stage. In
situ hybridization reveals a high, ubiquitous expression
pattern in the embryonic CNS, while in the adult brain,
Bmi-1 expression level is low and restricted to the SVZ,
hippocampus, and olfactory bulb (GENSAT and Allen-
Brain Atlas). This is in agreement with our data showing
thatBmi-1 protein levels are higher at E11 than in the adult
(data not shown). Thus, knockdown of Bmi-1 in adult
NPCs would reduce the absolute levels of Bmi-1 more
than at embryonic stages, which might be responsible
for a more dramatic phenotype.
The increased dependence could also be due to the in-
terplay of stage-related proliferation regulators. We found
stage-related differences in expression of genes involved
in Rb regulation after Bmi-1 shRNA treatment at different
stages (Figure 7 and Figure S5). After Bmi-1 knockdown,
the Rb interacting proteins Ctbp1 and E4F1, which stabi-
lize the Rb-E2F complex (Fajas et al., 2000; Liu et al.,
2006), were downregulated in E11 NPCs but upregulated
in E16 NPCs. Interestingly, E4F1 is a downstream media-
tor of proliferation in hematopoietic stem cells (Chagraoui
et al., 2006). Concomitant treatment of HSCs with E4F1
and Bmi-1 shRNA results in a complete rescue of the pro-
liferative defect seen in Bmi-1 shRNA-treated HSCs. This
fits nicely with our data, as E4F1 decreases at E11 but in-
creases at E16, thus offering a possible mechanism as to
why the Bmi-1 shRNA phenotype in early NPCs is not as
severe. In addition, we observed an upregulation of the
b-catenin signaling components Tcf4 and its transcrip-
tional target Id2 at E11, but not at E16. Early stage fore-
brain progenitor cells are stimulated to divide and gener-
ate neurons by b-catenin signaling (Chenn and Walsh,
2002; Hirabayashi et al., 2004; Zechner et al., 2003;
Shen et al., 2004). Id2 is normally expressed in ventricular
zone cells at high levels, where it can inhibit bHLH differ-
entiation pathways (Neuman et al., 1993), and Id2 can96 Cell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc.directly bind to Rb and inactivate it (Lasorella et al.,
2005). These observations raise the hypothesis that
Bmi-1-dependent regulation of p21-Rb pathway compo-
nents alters NSC self-renewal properties at different
stages of development.
In conclusion, we have identified p21 as a focus of Bmi-
1-mediated repression in self-renewing NSCs throughout
development and identified putative targets of Bmi-1 reg-
ulation that differ in NSCs at different stages of develop-
ment. It is unclear how Bmi-1 regulates p21 expression,
whether by direct or indirect means; this will be important
to elucidate in the future. Identification of p21-Rb pathway
components as downstream effectors in the Bmi-1-medi-
ated self-renewal pathway heightens our interest in these
molecules for involvement in deregulated self-renewal, as
in CNS tumors (Hemmati et al., 2003; Leung et al., 2004).
Bmi-1 can be upregulated in brain tumors, such asmedul-
loblastoma and glioblastoma, which have been linked to
a stem cell-like origin (Hemmati et al., 2003; Leung et al.,
2004; Glinsky et al., 2005). There is evidence that glioblas-
toma progression occurs with a loss of p21 induction (Jen-
nings and Pietenpol, 1998) and that upregulation of p21
can inhibit glioblastoma growth (Seoane et al., 2004).
The transcription factor Olig2 is critical for proliferation
of normal and tumorigenic CNS stem cells and does so
by repressing p21 (Ligon et al., 2007). It will be important
to investigate the role of Bmi-1 in p21-Rb-dependent tu-
mor growth. Moreover, the findings reported here of a
role for Bmi-1 in differentially regulating p21-Rb pathway
components at different stages of development provide
potential new targets for brain tumors that arise at different
ages.
EXPERIMENTAL PROCEDURES
Neural Progenitor Cell Culture
Adherent culture: cerebral cortices of timed pregnant Swiss Webster
mouse embryos (E11–E16) were dissected and dissociated as de-
scribed previously (Qian et al., 1998). Adult SVZ cells were isolated
from 6–8 week old Swiss Webster mice (Taconic Farms) and dissoci-
ated as previously described (Sun et al., 2005). Single dissociated cells
were plated into poly-L-lysine (PLL, Sigma) coated Terasaki plates or
6-well plates and cultured in a serum-free culture medium: DMEM,
L-glutamine, Na-pyruvate, B-27 supplemented with N-2 (Gibco), and
1 mM N-acetyl-cysteine (Sigma) with 10 ng/ml FGF2 (Gibco). For
clonal analysis, single cells were plated at a density of 10–20 cells/
well (E11), 40–60 cells/well (E14), or 60–80 cells/well (E16) in Terasaki
microwells, and clonal development was monitored by daily micro-
scopic inspection.
Neurosphere culture: Single dissociated cortical cells were cultured
in uncoated 6-well plates for 7 days, in serum-free medium with EGF
and FGF2 (20 ng/ml each) following typical neurosphere growth proto-
cols (Tropepe et al., 1999). All conditions were done in duplicate and
repeated 2–4 times. For subcloning, neurospheres were collected
and gently dissociated using papain (Worthington) at 37C for 20 min
with gentle agitation. Cells were replated at equal cell density for
each condition, and numbers of neurospheres were counted after
7 days by microscopy.
Histochemistry
Sixteen micrometer coronal forebrain cryostat sections of paraformal-
dehyde-fixed brains were immunostained as described previously with
primary antibodies incubated overnight at 4C (Shen et al., 2006).
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ufacturer’s protocols.
Cell cultures were fixed with 4% paraformaldehyde and immuno-
stained overnight at 4C with primary antibody as described (Shen
et al., 2006). Primary antibody uses the following: monoclonal antibody
b-tubulin III, mouse IgG2b (Sigma), 1:800; rabbit eGFP (Molecular
Probes), 1:1000; NG2 rabbit (Chemicon) 1:400; and O4, IgM (Develop-
mental Hybridoma Bank), 1:2. Alexa Fluor-conjugated secondary anti-
bodies (Molecular Probes, 1:1000) were incubated 45 min at room
temperature (RT). Phase and fluorescent images were taken with
a Zeiss Axiovert 200 inverted microscope and a Zeiss AxioCam
MRm digital camera with AxioVision 4 software.
In Utero Electroporation
Plasmids were transfected in vivo by electroporation (Bai et al., 2003).
Briefly, E14–E15 CD1 mice were anesthetized with isoflurane, 5% for
induction and 3% for maintenance. The uterine horns were exposed,
and 1–1.5 ml (DNA 1 to 2 mg/ml) of plasmids in saline with fast green
(2 mg/ml; Sigma) were microinjected (Nanonject II, Drummond Scien-
tific) into the lateral ventricles. A 500 mF capacitor charged to 50V–
100V was discharged across the head via copper alloy plates. Three
sections from each animal were used to calculate average of eGFP+
cells in each region; three different animals were used to generate aver-
ages.Regionsweredelineatedaspreviouslydescribed (Bai et al., 2003).
Vector Production and Viral Packaging
A third-generation lentiviral vector FUGW (Lois et al., 2002) was mod-
ified to express an shRNA from the H1 promoter as described (Ivanova
et al., 2006). Briefly, an oligonucleotide was synthesized that consisted
of a sequence-specific 19 nucleotide stretch designed to target the
Bmi-1 ORF (GAGATAATAAGCTTGTCTA and ACAACCAGAATCAAG
ATCA) or the Bmi-1 30UTR (ATATGGATGTTAAGTGGAA) followed by
the loop sequence (TTCAAGAGA) and finally the reverse complement
of the targeting sequence. A termination sequence (AX6) and a 50 clon-
ing site (GT) were added to facilitate directional cloning immediately
downstream of the H1 promoter using XbaI/SmaI cloning sites. An
example of the full sequence for Bmi-1 ORF shRNA is GAGATAATA
AGCTTGTCTATTCAAGAGATAGACAAGCTTATTATCACAAAAAAGT.
For p21 shRNA, the sequences used were TTAGGACTCAACCGT
AATA and AGTAGCAGTTGTACAAGGA, both targeted against the
ORF. Data were collected using the first sequence (four experiments)
and the phenotype was verified using the second sequence (two ex-
periments) to ensure specificity. For Ink4a/Arf shRNA the sequence
AATGGCTGGATTGTTTAAAwas used. Ink4a/Arf shRNA rescue exper-
iments were done in triplicate and repeated twice.
This shRNA-expressing lentiviral plasmid was cotransfected with
plasmids pVSV-G and pCMVd8.9 into 293FT cells. Viral containing
media were collected, filtered, and concentrated by ultracentrifuga-
tion. Viral titers were measured by serial dilution on NIH 3T3 cells fol-
lowed by flow cytometric analysis after 48 hr. For viral transduction,
lentiviral vectors at a multiplicity of infection (moi) of 10 were added
to dissociated cortical cells prior to or just after plating.
Lentiviral Overexpression
Using siRNA sequences targeting the 30UTR of Bmi-1 allowed us the
opportunity to perform a rescue experiment by coexpressing the
Bmi-1 ORF. The original lentiviral construct was derived from FUGW
(Lois et al., 2002). The Bmi-1 clone was obtained from OpenBiosys-
tems and cloned into the modified vector driving transgene expression
with a ubiquitin promoter and an IRES eGFP for visualization in cells.
Viral transduction was accomplished as described above. For rescue
experiments, cells were cotransduced with pUbqC-Bmi-1 and Bmi-1
shRNA 30UTR at equal moi. Bmi-1 mRNA and protein levels in cells
were measured 48 hr posttransduction.
Agilent Microarray Procedures
Total RNA was extracted from viral-transduced cells using Trizol re-
agent (Invitrogen) as recommended by the manufacturer and treatedwith DNase I. RNA was reverse transcribed, then Cy3 or Cy5 labeled
cRNA was prepared using the Low Input Linear cRNA Amplification
Kit from Agilent, according to manufacturer’s instructions. The Agilent
Oligo 44K mouse genome sequence in situ microarrays were used for
all studies (Agilent, G4122A). Microarrays were hybridized, washed,
and scanned according to manufacturer’s instructions. Raw data
have been deposited with the Princeton University MicroArray Data-
base, PUMAdb (http://puma.princeton.edu/).
Microarray Data Analysis
Raw images were first analyzed using GenePix software. Total and
local background were measured, and if an individual spot intensity
in either fluorescent channel was at or below background it was ex-
cluded from further analysis. All downstream analyses were performed
with software publicly available from The Institute for Genomic Re-
search (Saeed et al., 2003). The resulting GenePix files were converted
to TIGR MeV file formats, and then all control features were removed.
Data were subjected to locally weighted linear regression (LOWESS)
normalization, performed with MIDAS (Quackenbush, 2002 and Saeed
et al., 2003). LOWESS normalization removes intensity-dependent
effects in calculated log2 ratio values, and thereby allows for cross-
chip comparison of gene expression data.
Dye-flip experiments were performed for every experiment and
analyzed using MIDAS. Dye-flip hybridizations were used to filter out
features that showed expression level inconsistency between the
pair of replicates. For each feature pair between dye-swapped chips,
themean log ratio (A) and standard deviation (SD) were calculated, and
A was determined for all nonzero features on each chip (A0), which
should be near 0. A threshold of 2 SD was selected as default. All fea-
tures whose A was less than or equal to A0  2SD(A) or greater than or
equal to A0 + 2SD(A) were excluded from downstream analyses.
RNA from control and Bmi-1 RNAi cells were each hybridized with
a reference whole brain RNA preparation. Log ratios calculated for
control samples were subtracted from log ratios calculated from
Bmi-1 RNAi cultures for each developmental stage. These normalized
log ratios were processed in Excel and with MeV software packages.
Self-organizing trees and hierarchical clustering analysis were per-
formedwithMeV as described (Saeed et al., 2003). Genes were filtered
using a log2 ratio of greater than ±0.5; this cutoff removes all genes
whose differential expression is less than 2 SD.
Real-Time Quantitative PCR
Total RNA was extracted from viral-transduced cells using Trizol
reagent (Invitrogen) and treated with DNase I. cDNA was prepared
with SuperScript III (Invitrogen) and used as templates for PCR. PCR
core reagents and SYBR green (ABI) were usedwith 200 nM of forward
and reverse primers. Real-time quantitative PCR was performed with
the ABI PRISM7700 Sequence Detection System. A standard curve
was generated for each primer pair, and genes of interest were as-
signed a relative expression value interpolated from this standard
curve using the threshold cycle (Ct) according to ABI instructions. All
expression values were normalized against GAPDH. All amplifications
were done in duplicate, and at least four technical and two biological
replicates were performed. PCR primer sequences are available in
Table S3.
Western Blots
Protein was isolated using 2%SDSwith EDTA, and protein concentra-
tion was calculated using the BCA assay. Equal amounts of protein
(15–20 mg/lane) were loaded into 12% Invitrogen NuPAGE Novex
BisTris gels and transferred onto nitrocellulose membranes. For the
p21 blot, shRNAs were tested inmouse brain endothelial (Mbend) cells
(ATCC# CRL-2299, passage 6) in order to obtain sufficient protein for
the assay. Membranes were blocked with 5% milk for 2 hr at RT
and blotted overnight with antibody at 4C: Bmi-1 (Upstate Signaling
1:500), ERK2, and actin (Upstate Signaling 1:5000). Peroxidase-conju-
gated secondary antibodies (Jackson ImmunoResearch) were used atCell Stem Cell 1, 87–99, July 2007 ª2007 Elsevier Inc. 97
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Bmi-1 Represses p21 in NSCs1:10,000 for 1 hr at RT. ECL (Pierce) was the chemical substrate, and
blots developed with Kodak film.
Supplemental Data
Supplemental Data include five figures and three tables and can be
found with this article online at http://www.cellstemcell.com/cgi/
content/full/1/1/87/DC1/.
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